PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

Newsroom

This is where you can keep up with the latest news and browse featured resources, such as scientific articles relevant to our research and our own publications.

News

Resources

1

News

Coartem® Baby launches in Ghana

Coartem® Baby launches in Ghana

Coartem Baby is the first malaria medicine to be approved for young infants.

First malaria medicine for young infants 2-5 kg receives approval

First malaria medicine for young infants 2-5 kg receives approval

The new dose strength designed for young infants was developed by Novartis with the scientific and financial support of MMV, and as part of the PAMAfrica consortium.

View all News

1

Resources

PAMAfrica Infographic

Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa

Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa

Malaria Journal

Peer-reviewed article

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

Scientific Reports

Peer-reviewed article

PAMAfrica training initiatives: 2020–2023

PAMAfrica training initiatives: 2020–2023

An infographic detailing the training initiatives undertaken through PAMAfricas Work Package 4: Building research capacity in Africa

View all Resources